Olympus

Olympus was born in 1919, and after a century of accumulation and refinement, it has become a global medical technology company. Adhering to the corporate core values of "patient-first, integrity and responsibility, innovation and implementation, practice and realization, empathy and inclusiveness," Olympus technology, dedicated research and innovation, and services that exceed expectations provide solutions for professional customers, committed to the corporate mission of achieving the health, peace of mind, and happiness of people worldwide, continuously contributing to society.

In the field of gastrointestinal endoscopy, Olympus provides: electronic endoscope series products that meet the needs of endoscopists for screening lesions, identifying lesions, and treating lesions, endoscopic diagnosis and treatment accessories, and also provides endoscope cleaning and disinfection equipment, offering a full closed-loop product and solution from "diagnosis" to "treatment" to "cleaning and disinfection"; In the surgical field, Olympus aims at "minimal traumatic invasion, maximal organ protection, and optimal rehabilitation effects," providing various types of imaging systems, energy platforms, specialized equipment, and instruments.

Olympus has always been committed to innovative technologies and products, serving all aspects of clinical diagnosis and treatment. Olympus's NBI narrow-band imaging technology improves imaging contrast and clarity by enhancing the display of superficial microvessels and fine surface structures of the mucosa, making the characteristics of early cancer more obvious and effectively improving the early diagnosis rate of gastrointestinal diseases. On this basis, Olympus has also launched the "EC endoscope," which has 520x optical magnification, enabling in vivo observation at the cellular level. By integrating endoscope technology with industrial technologies such as laparoscopic 3D/4K ultra-high-definition imaging systems, minimally invasive surgery is more assured, providing medical staff with high-definition imaging effects and flexible and comprehensive observation fields, improving surgical efficiency, shortening minimally invasive surgery time, and enhancing patients' quality of life.

At the same time, to advance the development of endoscopic treatment and minimally invasive technology in China and meet the needs of medical workers for medical technology, since 2009, C-TEC (China Medical Technology Training Center) has been established in Shanghai, Beijing, and Guangzhou. C-TEC uses professional knowledge and technology to build a platform for medical workers to continuously learn, communicate, and develop.

As a responsible corporate citizen, Olympus always treats society with sincerity, creates value, contributes to society, and wins more respect. Therefore, while continuously developing technologies and products and improving services, Olympus has launched colorful corporate social responsibility activities in multiple fields such as gastrointestinal health, environmental protection, science education, social donations, and employee care, demonstrating the company's sense of mission and humanistic care. For a long time, Olympus has been conveying healthy lifestyles and the scientific "three early" concept of "early detection, early diagnosis, early treatment" to the public, eliminating the public's fear of cancer and endoscopic examinations. Up to now, Olympus's public welfare footprint has spread to more than 40 cities in China, affecting more than 120 million people.

With the end of the COVID-19 pandemic, China's economy is expected to recover rapidly. At the same time, China's importance in Olympus's global market is gradually increasing, and the group has high expectations for the continuous growth of the medical business in China. To achieve this goal, we will further deepen the implementation of the China strategy. In January 2023, the group made an important decision to establish a medical device manufacturing plant in China, and in March 2023, Olympus (Suzhou) Medical Devices Co., Ltd. was established in Suzhou. Next, we will thoroughly implement the China strategy and improve the operation system of the new plant to promote the further development of the China region.

Time keeps moving forward. Olympus has continuously accumulated and broken through in its century-long development, setting an example in the industry and actively contributing. As an important region in Olympus's next century strategy, China will lead the group toward sustainable development goals in the future. All employees in the China region will uphold the company's business philosophy and, under the guidance of core values, make more contributions to achieving the health, peace of mind, and happiness of people around the world and creating higher value for Chinese society.